GB201223021D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB201223021D0
GB201223021D0 GBGB1223021.5A GB201223021A GB201223021D0 GB 201223021 D0 GB201223021 D0 GB 201223021D0 GB 201223021 A GB201223021 A GB 201223021A GB 201223021 D0 GB201223021 D0 GB 201223021D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1223021.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
UCB Pharma SA
KU Leuven Research and Development
Original Assignee
Katholieke Universiteit Leuven
UCB Pharma SA
KU Leuven Research and Development
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven, UCB Pharma SA, KU Leuven Research and Development filed Critical Katholieke Universiteit Leuven
Priority to GBGB1223021.5A priority Critical patent/GB201223021D0/en
Publication of GB201223021D0 publication Critical patent/GB201223021D0/en
Priority to KR1020157018482A priority patent/KR102215490B1/en
Priority to SG11201504291SA priority patent/SG11201504291SA/en
Priority to MX2015007774A priority patent/MX2015007774A/en
Priority to LTEP13814962.0T priority patent/LT2935269T/en
Priority to PL13814962T priority patent/PL2935269T3/en
Priority to ES13814962.0T priority patent/ES2676515T3/en
Priority to DK13814962.0T priority patent/DK2935269T3/en
Priority to PCT/EP2013/077846 priority patent/WO2014096423A1/en
Priority to AP2015008552A priority patent/AP2015008552A0/en
Priority to US14/650,771 priority patent/US9714248B2/en
Priority to PT138149620T priority patent/PT2935269T/en
Priority to AU2013366480A priority patent/AU2013366480B2/en
Priority to SI201331080T priority patent/SI2935269T1/en
Priority to TR2018/09140T priority patent/TR201809140T4/en
Priority to MA38279A priority patent/MA38279B1/en
Priority to HUE13814962A priority patent/HUE038310T2/en
Priority to SG10201703094UA priority patent/SG10201703094UA/en
Priority to CN201380066813.4A priority patent/CN105008360B/en
Priority to PE2015001053A priority patent/PE20151767A1/en
Priority to CA2893704A priority patent/CA2893704C/en
Priority to MYPI2015701917A priority patent/MY189182A/en
Priority to EP13814962.0A priority patent/EP2935269B1/en
Priority to EA201500654A priority patent/EA027752B1/en
Priority to BR112015014869A priority patent/BR112015014869A2/en
Priority to NZ709360A priority patent/NZ709360A/en
Priority to JP2015548662A priority patent/JP6298830B2/en
Priority to PH12015501222A priority patent/PH12015501222A1/en
Priority to IL239163A priority patent/IL239163B/en
Priority to CL2015001752A priority patent/CL2015001752A1/en
Priority to SA515360627A priority patent/SA515360627B1/en
Priority to TNP2015000285A priority patent/TN2015000285A1/en
Priority to GT201500169A priority patent/GT201500169A/en
Priority to CR20150379A priority patent/CR20150379A/en
Priority to ECIEPI201531293A priority patent/ECSP15031293A/en
Priority to HK16103653.4A priority patent/HK1215705A1/en
Priority to HRP20181008TT priority patent/HRP20181008T1/en
Priority to CY20181100728T priority patent/CY1120415T1/en
Priority to US16/517,969 priority patent/USRE48622E1/en
Ceased legal-status Critical Current

Links

GBGB1223021.5A 2012-12-20 2012-12-20 Therapeutic agents Ceased GB201223021D0 (en)

Priority Applications (39)

Application Number Priority Date Filing Date Title
GBGB1223021.5A GB201223021D0 (en) 2012-12-20 2012-12-20 Therapeutic agents
PE2015001053A PE20151767A1 (en) 2012-12-20 2013-12-20 THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES
CN201380066813.4A CN105008360B (en) 2012-12-20 2013-12-20 The Pyrazolopyrimidine derivative of therapeutic activity
TR2018/09140T TR201809140T4 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives.
MX2015007774A MX2015007774A (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives.
LTEP13814962.0T LT2935269T (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
PL13814962T PL2935269T3 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
ES13814962.0T ES2676515T3 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
DK13814962.0T DK2935269T3 (en) 2012-12-20 2013-12-20 THERAPEUTIC ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES.
PCT/EP2013/077846 WO2014096423A1 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
AP2015008552A AP2015008552A0 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
US14/650,771 US9714248B2 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
PT138149620T PT2935269T (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
AU2013366480A AU2013366480B2 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
SI201331080T SI2935269T1 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
MYPI2015701917A MY189182A (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
MA38279A MA38279B1 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
HUE13814962A HUE038310T2 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
SG10201703094UA SG10201703094UA (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
KR1020157018482A KR102215490B1 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
CA2893704A CA2893704C (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives as inhibitors of phosphatidyl-inositol-4-kinase iiib (pi4kiiib) activity
JP2015548662A JP6298830B2 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
SG11201504291SA SG11201504291SA (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
EP13814962.0A EP2935269B1 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
EA201500654A EA027752B1 (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
BR112015014869A BR112015014869A2 (en) 2012-12-20 2013-12-20 therapeutically active pyrazolo pyrimidine derivatives
NZ709360A NZ709360A (en) 2012-12-20 2013-12-20 Therapeutically active pyrazolo-pyrimidine derivatives
PH12015501222A PH12015501222A1 (en) 2012-12-20 2015-06-01 Therapeutically active pyrazolo-pyrimidine derivatives
IL239163A IL239163B (en) 2012-12-20 2015-06-03 Therapeutically active pyrazolo-pyrimidine derivatives
TNP2015000285A TN2015000285A1 (en) 2012-12-20 2015-06-18 Therapeutically active pyrazolo-pyrimidine derivatives
CL2015001752A CL2015001752A1 (en) 2012-12-20 2015-06-18 Compounds derived from pyrazolo-pyramidine, selective inhibitors of phosphatidyl-inositol-4-kinase iii beta activity (pi4kiiib); pharmaceutical composition; and its use for the treatment or prevention of an inflammatory, autoimmune or oncological disorder, a viral disease or malaria or rejection of organ or cell transplantation
SA515360627A SA515360627B1 (en) 2012-12-20 2015-06-18 Therapeutically active pyrazolo-pyrimidine derivatives
GT201500169A GT201500169A (en) 2012-12-20 2015-06-19 THERAPEUTICALLY ACTIVE DERIVATIVES OF PIRAZOL-PYRIMIDINE
CR20150379A CR20150379A (en) 2012-12-20 2015-07-17 DERIVATIVES OF PIRAZOLO-PYRIMIDINE THERAPEUTICALLY ACTIVE
ECIEPI201531293A ECSP15031293A (en) 2012-12-20 2015-07-20 THERAPEUTICALLY ACTIVE PYRAZOLO-PYRIMIDINE DERIVATIVES
HK16103653.4A HK1215705A1 (en) 2012-12-20 2016-03-30 Therapeutically active pyrazolo-pyrimidine derivatives
HRP20181008TT HRP20181008T1 (en) 2012-12-20 2018-06-28 Therapeutically active pyrazolo-pyrimidine derivatives
CY20181100728T CY1120415T1 (en) 2012-12-20 2018-07-11 PYRAZOLO-PYRIMIDINE TREATMENT ACTIVE PRODUCTS
US16/517,969 USRE48622E1 (en) 2012-12-20 2019-07-22 Therapeutically active pyrazolo-pyrimidine derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1223021.5A GB201223021D0 (en) 2012-12-20 2012-12-20 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB201223021D0 true GB201223021D0 (en) 2013-02-06

Family

ID=47682284

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1223021.5A Ceased GB201223021D0 (en) 2012-12-20 2012-12-20 Therapeutic agents

Country Status (4)

Country Link
EC (1) ECSP15031293A (en)
GB (1) GB201223021D0 (en)
GT (1) GT201500169A (en)
MA (1) MA38279B1 (en)

Also Published As

Publication number Publication date
ECSP15031293A (en) 2018-07-31
MA38279A1 (en) 2018-02-28
MA38279B1 (en) 2018-10-31
GT201500169A (en) 2019-08-30

Similar Documents

Publication Publication Date Title
HK1203963A1 (en) Novel therapeutic agents
HK1211475A1 (en) Combination therapy
GB201212513D0 (en) Therapeutic agents
ZA201305897B (en) Combination therapy
EP2814472A4 (en) Dithioamine reducing agents
GB201114212D0 (en) Therapeutic agents
EP2906208A4 (en) Therapeutic treatment
ZA201400120B (en) Combination therapy
GB201119401D0 (en) Therapeutic agents
EP2867209A4 (en) Compounds and therapeutic uses thereof
GB201217439D0 (en) Combination therapy
GB201217704D0 (en) Therapeutic agents
GB201910190D0 (en) Optimised subsutaneous therapeutic agents
GB201207305D0 (en) Therapy
EP2701744A4 (en) Combination therapy
GB201420971D0 (en) Therapeutic composition
HK1210426A1 (en) Combination therapy
EP2688566A4 (en) Anticancer therapeutic agents
IL217807A0 (en) Therapeutic compositions
HK1210474A1 (en) Therapeutic bisphosphonates
EP2804853A4 (en) Therapeutic uses
ZA201405764B (en) Novel therapeutic agents
GB201223021D0 (en) Therapeutic agents
GB201212512D0 (en) Therapeutic agents
GB201210233D0 (en) Therapeutic agents

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)